TransPerfect
, a leading provider of e-clinical technologies to the
life sciences
industry, today announced that
Worldwide Clinical Trials
(WCT) has selected
Trial Interactive
as its electronic Trial Master File (eTMF) solution to streamline global study management. Trial Interactive is a web-based, 21 CFR Part 11 compliant platform that eliminates the redundancies inherent in paper-based TMF studies.
“With Trial Interactive as our eTMF solution, we will be able to deliver near real-time access to eTMFs for our clients, and we will improve overall processes in managing TMF documentation,” said Tom Wardle, Chief Operating Officer of WCT.
By providing study stakeholders with real-time access to
clinical trial documentation
, Trial Interactive eliminates travel and shipping costs associated with review and reconciliation, thereby streamlining clinical development programs for WCT and its sponsors. In addition, Trial Interactive’s interface is available in more than 20 languages, which will enable WCT to deploy the solution in the local language of the end user, including global study teams, sponsors, and investigative site personnel.
Michael Smyth, General Manager of TransPerfect Life Sciences Solutions, added, “We are proud that WCT has chosen Trial Interactive as its eTMF solution, and we’re pleased to support their ultimate goal of a paperless clinical trial.”
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.